Viridian Therapeutics (VRDN)
(Delayed Data from NSDQ)
$13.90 USD
-0.01 (-0.07%)
Updated May 10, 2024 04:00 PM ET
After-Market: $13.90 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.87 | 0.00% |
Earnings Summary
For their last quarter, Viridian Therapeutics (VRDN) reported earnings of -$0.79 per share, beating the Zacks Consensus Estimate of $-1.07 per share. This reflects a positive earnings surprise of 26.17%. Look out for VRDN's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.87 per share, reflecting a year-over-year increase of 31.5%.
Earnings History
Price & Consensus
Zacks News for VRDN
How Much Upside is Left in Viridian Therapeutics, Inc. (VRDN)? Wall Street Analysts Think 97.81%
VRDN: What are Zacks experts saying now?
Zacks Private Portfolio Services